GOT MIGRAINE?

DEAD

Serial Number

87606536

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark D. Simpson

Filing Date

Sep 13, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GOT MIGRAINE? Trademark

Serial Number: 87606536

GOT MIGRAINE? is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on September 13, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Mark D. Simpson

683 trademarks filed View all →

Trademark Details

Filing Date

September 13, 2017

Registration Date

Not Registered

Published for Opposition

September 18, 2018

Goods & Services

Downloadable electronic publications in the nature of information kits comprised of downloadable brochures, books, e-books, booklets, advertising materials, convention handouts, training materials, and catalogs, all on migraines

Medical information services, namely, providing information related to migraines; providing an Internet website portal featuring medical information for use by migraine sufferers

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 14, 2020 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Dec 14, 2020 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 15, 2020 EXRA

SOU EXTENSION 3 GRANTED

May 13, 2020 EX3G

SOU EXTENSION 3 FILED

May 13, 2020 EXT3

SOU TEAS EXTENSION RECEIVED

May 13, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 15, 2019 EXRA

SOU EXTENSION 2 GRANTED

Nov 13, 2019 EX2G

SOU EXTENSION 2 FILED

Nov 13, 2019 EXT2

SOU TEAS EXTENSION RECEIVED

Nov 13, 2019 EEXT

CORRECTED NOA E-MAILED

Jun 5, 2019 NOAC

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 1, 2019 EXRA

SOU EXTENSION 1 GRANTED

May 31, 2019 EX1G

DIVISIONAL PROCESSING COMPLETE

May 31, 2019 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 29, 2019 AITU

SOU EXTENSION 1 FILED

May 13, 2019 EXT1

DIVISIONAL REQUEST RECEIVED

May 13, 2019 DRRR

SOU TEAS EXTENSION RECEIVED

May 13, 2019 EEXT

TEAS REQUEST TO DIVIDE RECEIVED

May 13, 2019 ERTD

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 13, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 18, 2018 NPUB

PUBLISHED FOR OPPOSITION

Sep 18, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 29, 2018 NONP

ASSIGNED TO LIE

Aug 13, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 3, 2018 CNSA

EXAMINER'S AMENDMENT ENTERED

Aug 3, 2018 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 3, 2018 GNEN

EXAMINERS AMENDMENT E-MAILED

Aug 3, 2018 GNEA

EXAMINERS AMENDMENT -WRITTEN

Aug 3, 2018 CNEA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 21, 2018 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 21, 2018 REAP

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 21, 2018 TCCA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 21, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 21, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 21, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 21, 2017 GNRN

NON-FINAL ACTION E-MAILED

Dec 21, 2017 GNRT

NON-FINAL ACTION WRITTEN

Dec 21, 2017 CNRT

ASSIGNED TO EXAMINER

Dec 18, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 18, 2017 NWOS

NEW APPLICATION ENTERED

Sep 16, 2017 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

INVICTUS

HEREWIN